LYNX1 CAPITAL MANAGEMENT LP enters NEUPHORIA THERAPEUTICS INC. with 236.22K shares across direct and indirect positions
This filing by LYNX1 CAPITAL MANAGEMENT LP establishes the baseline for all future Form 4 insider transaction reports at NEUPHORIA THERAPEUTICS INC..
Indirect
Filed: 10/23/2025ACC: 0000902664-25-004535
10% Owner
Since Oct 2025
236.22K
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
236.22K indirect
Non-Derivative Holdings1
Common stock, $0.00001 par value per share
IndirectShares owned236.22K
Total
236.22K indirect236.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock, $0.00001 par value per share | 236.22K | Indirect |
| Total | 236.22K | 236.22K indirect |
Derivative Holdings0
No derivative holdings reported